Meteoric Resources (ASX:MEI)
When it comes to metals, there is huge potential given current market conditions. Base and precious metals are seeing renewed demand, along with rising prices.
The question is how can investors capitalise on the changing landscape?
One Perth-based company has recently listed on the ASX and moved into primetime metals commercialisation.
It has assembled a blend of base metal assets, including cobalt, nickel and copper, in Canada — a region with many commercial possibilities.
This company now has four distinct prospects with around US$20 million of historical data on hand and most recently took possession of additional cobalt ground at its Mulligan Cobalt Project.
Everyone agrees that the electric-vehicle revolution has arrived but beyond that there is no consensus as to how fast it might evolve. Cobalt has the legs to reach higher highs, and welcome a heap of aspirational cobalt suppliers to market — including the early-moving MEI, priced at a just $0.067 per share with a market capitalisation of A$30 million.
The information on this page should not be the only trigger for your investment decision. Click on the link below for a more in-depth and informed examination of the company. We strongly recommend you seek professional financial advice whenever making financial investment decisions.
If you’re looking for a ground-floor entry into tomorrow’s energy renaissance fuelled by new-age metals and efficient energy use — the polymetallic cobalt-wielding MEI could be the way to go.
MEI Strengthens Cobalt Exploration Across Expanded Portfolio
Aug 2, 2018
Meteoric Resources (ASX:MEI) has assembled a quality package of highly prospective primary cobalt projects in the Canadian state of Ontario. This region is particularly notable as a mining friendly jurisdiction, which hosts some of the highest grade cobalt deposits of anywhere in the world.
Related Meteoric Resources (ASX:MEI) articles
Moto went from 4¢ to $4: This ASX Explorer has Same Backer, Same Country, Same Metal… Same Result?
Aug 16, 2019
One ASX Med-Tech is Set to Transform The $100+Billion Cancer Diagnostic Market
Aug 14, 2019